Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19

15 Mar 2021

Abstract excerpt

Current coronavirus disease-2019 (COVID-19) pandemic has caused massive loss of lives. Clinical trials of vaccines and drugs are currently being conducted around the world; however, till now no effective drug is available for COVID-19. Identification of key genes and perturbed pathways in COVID-19 may uncover potential drug targets and biomarkers. We aimed to identify key gene modules and hub targets involved in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Drug Discovery Methods
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33839760
DOI: 10.1093/bib/bbab120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19PMID 33839760Read ↗

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read ↗

Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysisSemantic proximity Read ↗

Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cellsSemantic proximity Read ↗

Identifying potential novel insights for COVID-19 pathogenesis and therapeutics using an integrated bioinformatics analysis of host transcriptomeSemantic proximity Read ↗

Identification of hub genes and molecular subtypes in COVID-19 based on WGCNA.Semantic proximity Read ↗

Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysisSemantic proximity Read ↗

Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approachesSemantic proximity Read ↗

Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19Semantic proximity Read ↗

Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysisSemantic proximity Read ↗

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in severe acute respiratory syndrome corona virus 2 infection/COVID 19Semantic proximity Read ↗

Modeling COVID-19 disease biology to identify drug treatment candidatesSemantic proximity Read ↗

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.